A single measurement of fecal hemoglobin concentration outperforms polygenic risk score in colorectal cancer risk assessment
View ORCID ProfileTobias Niedermaier, Elizabeth Alwers, Xuechen Chen, Thomas Heisser, Michael Hoffmeister, Hermann Brenner
doi: https://doi.org/10.1101/2022.07.22.22277924
Tobias Niedermaier
1Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany
PhDElizabeth Alwers
1Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany
PhDXuechen Chen
1Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany
2Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany
PhD studentThomas Heisser
1Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany
2Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany
PhD studentMichael Hoffmeister
1Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany
Roles: Associate Professor in epidemiology
Hermann Brenner
1Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany
3Division of Preventive Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany
4German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany
Roles: Professor in epidemiology
Data Availability
Data availability: All data produced in the present study are available upon reasonable request to the authors.
Posted July 22, 2022.
A single measurement of fecal hemoglobin concentration outperforms polygenic risk score in colorectal cancer risk assessment
Tobias Niedermaier, Elizabeth Alwers, Xuechen Chen, Thomas Heisser, Michael Hoffmeister, Hermann Brenner
medRxiv 2022.07.22.22277924; doi: https://doi.org/10.1101/2022.07.22.22277924
A single measurement of fecal hemoglobin concentration outperforms polygenic risk score in colorectal cancer risk assessment
Tobias Niedermaier, Elizabeth Alwers, Xuechen Chen, Thomas Heisser, Michael Hoffmeister, Hermann Brenner
medRxiv 2022.07.22.22277924; doi: https://doi.org/10.1101/2022.07.22.22277924
Subject Area
Subject Areas
- Addiction Medicine (404)
- Allergy and Immunology (713)
- Anesthesia (208)
- Cardiovascular Medicine (2972)
- Dermatology (254)
- Emergency Medicine (446)
- Epidemiology (12821)
- Forensic Medicine (12)
- Gastroenterology (833)
- Genetic and Genomic Medicine (4625)
- Geriatric Medicine (424)
- Health Economics (733)
- Health Informatics (2944)
- Health Policy (1074)
- Hematology (394)
- HIV/AIDS (935)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (476)
- Neurology (4417)
- Nursing (238)
- Nutrition (653)
- Oncology (2298)
- Ophthalmology (653)
- Orthopedics (260)
- Otolaryngology (327)
- Pain Medicine (284)
- Palliative Medicine (85)
- Pathology (503)
- Pediatrics (1201)
- Primary Care Research (503)
- Public and Global Health (7011)
- Radiology and Imaging (1549)
- Respiratory Medicine (922)
- Rheumatology (446)
- Sports Medicine (386)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (185)